-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 17, Longbai Group (002601) issued an announcement that the 31st meeting of the company's seventh board of directors held on January 17, 2022 reviewed and approved the "Regarding the investment and construction of an annual output of 200,000 tons of titanium dioxide.
In order to make full use of the company's advantages in titanium dioxide research and development, production, sales and comprehensive utilization of resources, and further increase the market share of titanium dioxide, the company's wholly-owned subsidiary Longbai Xiangyang Titanium Industry Co.
, Ltd.
(hereinafter referred to as "" Longbai Xiangyang") plans to invest in the construction of a titanium dioxide post-processing project with an annual output of 200,000 tons
.
In order to make full use of the company's advantages in titanium dioxide research and development, production, sales and comprehensive utilization of resources, and further increase the market share of titanium dioxide, the company's wholly-owned subsidiary Longbai Xiangyang Titanium Industry Co.
, Ltd.
(hereinafter referred to as "" Longbai Xiangyang") plans to invest in the construction of a titanium dioxide post-processing project with an annual output of 200,000 tons
.